Study examines Global Health Impact of Fukushima

By Admin
Follow @WDMEllaCopeland Scientists have calculated the Global Health Impact of the Fukushima Nuclear Crisis, following widespread speculation about the...

Scientists have calculated the Global Health Impact of the Fukushima Nuclear Crisis, following widespread speculation about the global impact of the disaster.

Researchers from Stanford University calculated that radiation from the nuclear meltdown in March 2011 may cause as many as 1,300 cancer deaths globally, following a study which assessed the fallout from the crippled reactors.

To read the latest edition of Healthcare Global, click here


In addition to this, the disaster could potentially cause 2,500 cases of cancer, which will be mostly contained in Japan, according to the study. To estimate the potential radiation, scientists at Stanford University incorporated emissions estimates into a 3D global atmospheric model, which predicted the effects of radiation exposure – detected as far away as in the US and Europe.

Cancer cases may have been a minimum of ten times greater if the 81 percent of the radiation hadn’t fallen in the sea, according to Mark Jacobson, co-author of the report.

Despite the research, figures on potential cancer cases remain speculative, estimated from 24 to 2,500. The best estimate is 180, according to the research. The U.S. was predicted to experience somewhere between 0 and 30 cancer morbidities as a result of the disaster, but this is based on a very small concentration of radiation.

The overall global impact will be relatively low, according to the study’s co-author John Ten Hoeve. He added that they should “serve to manage the fear in other countries that the disaster had an extensive global reach.”




Featured Articles

Digital evolution delivers better healthcare outcomes

Hannah Graham, Group Account Director at digital transformation consultancy Equator, shares how digitisation is building positive changes in healthcare

Hyfe AI uses acoustic AI in its digital cough monitoring

Hyfe uses acoustic AI in its digital cough monitoring. Dr. Joe Brew, Co-Founder & CEO of Hyfe AI, tells us more about coughing technology post-COVID-19

Siemens: smart finance to help medical technology growth

Penny Pinnock, Business Development Manager at Siemens Financial Services UK, discusses how adopting digital technology can support the healthcare sector

Healthcare Digital news roundup: prostate cancer & AI

Medical Devices & Pharma

Lexica shares post-COVID-19 digital healthcare trends

Digital Healthcare

Medical devices expanding senior healthcare innovation

Medical Devices & Pharma